Literature DB >> 23843401

Tenofovir-related Fanconi's syndrome and osteomalacia in a teenager with HIV.

Julie M Lucey1, Peter Hsu, John B Ziegler.   

Abstract

A teenage boy with vertically acquired-HIV presented with bone pain of 6 months duration. His antiretroviral therapy (ART) consisted of tenofovir disoproxil fumarate (TDF), emtricitabine and ritonavir-boosted lopinavir. Plain X-rays showed stress fractures of metatarsals bilaterally. A dual emission X-ray absorptiometry scan revealed osteomalacia. Raised serum creatine, hypophosphataemia, glycosuria and metabolic acidosis supported a diagnosis of Fanconi's syndrome. Serum vitamin D levels were low. Discontinuation of TDF led to improvement in renal function, increase in serum phosphate and resolution of bone pain. This case uniquely features renal and skeletal toxicities with resultant metatarsal stress fractures. Children and adolescents on combined ART which include tenofovir should be screened for the early detection of proximal tubulopathy, with the measurement of renal function, phosphate, vitamin D and urinary phosphate excretion. Although uncommon and mostly reversible, recognition of tenofovir-related effects is paramount as prolonged exposure may lead to persistent renal tubular damage and osteomalacia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23843401      PMCID: PMC3736206          DOI: 10.1136/bcr-2013-008674

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Fanconi syndrome and renal failure induced by tenofovir: a first case report.

Authors:  David Verhelst; Matthieu Monge; Jean-Luc Meynard; Bruno Fouqueray; Béatrice Mougenot; Pierre-Marie Girard; Pierre Ronco; Jerome Rossert
Journal:  Am J Kidney Dis       Date:  2002-12       Impact factor: 8.860

2.  Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men.

Authors:  Karen Wever; Michiel A van Agtmael; Andrew Carr
Journal:  J Acquir Immune Defic Syndr       Date:  2010-09       Impact factor: 3.731

3.  Tenofovir-induced renal tubular dysfunction presenting with hypocalcaemia.

Authors:  John Williams; David R Chadwick
Journal:  J Infect       Date:  2005-08-25       Impact factor: 6.072

4.  Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir.

Authors:  Sabiha Hussain; Abeer Khayat; Asad Tolaymat; Mobeen H Rathore
Journal:  Pediatr Nephrol       Date:  2006-05-16       Impact factor: 3.714

5.  Tenofovir-induced osteomalacia.

Authors:  D P Wanner; A Tyndall; U A Walker
Journal:  Clin Exp Rheumatol       Date:  2009 Nov-Dec       Impact factor: 4.473

Review 6.  Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions.

Authors:  Anthony E Zimmermann; Thomas Pizzoferrato; John Bedford; Anne Morris; Robert Hoffman; Gregory Braden
Journal:  Clin Infect Dis       Date:  2005-12-08       Impact factor: 9.079

7.  Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus.

Authors:  Julia B Purdy; Rachel I Gafni; James C Reynolds; Steven Zeichner; Rohan Hazra
Journal:  J Pediatr       Date:  2008-04       Impact factor: 4.406

Review 8.  Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell.

Authors:  Kara K Wools-Kaloustian; Samir K Gupta
Journal:  Kidney Int       Date:  2008-10       Impact factor: 10.612

9.  High frequency of vitamin D deficiency in ambulatory HIV-Positive patients.

Authors:  M Rodríguez; B Daniels; S Gunawardene; G K Robbins
Journal:  AIDS Res Hum Retroviruses       Date:  2009-01       Impact factor: 2.205

10.  Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia.

Authors:  Lloyd B Mulenga; Gina Kruse; Shabir Lakhi; Ronald A Cantrell; Stewart E Reid; Isaac Zulu; Elizabeth M Stringer; Zipporah Krishnasami; Alwyn Mwinga; Michael S Saag; Jeffrey S A Stringer; Benjamin H Chi
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

View more
  12 in total

1.  Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases.

Authors:  Quentin Dardonville; Esther Salguiero; Vanessa Rousseau; Leila Chebane; Jean Luc Faillie; Sophie Gautier; Jean Louis Montastruc; Alfonso Carvajal; Haleh Bagheri
Journal:  Eur J Clin Pharmacol       Date:  2019-08-29       Impact factor: 2.953

2.  Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.

Authors:  Julie J Kim-Chang; Lorena Wilson; Cliburn Chan; Bernard Fischer; Guglielmo Venturi; Maureen M Goodenow; Grace Aldrovandi; Thomas J Weber; John W Sleasman
Journal:  AIDS Res Hum Retroviruses       Date:  2019-06-27       Impact factor: 2.205

3.  Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients.

Authors:  Lourdes Mateo; Susana Holgado; Maria Luisa Mariñoso; Ricard Pérez-Andrés; Anna Bonjoch; Joan Romeu; Alejandro Olivé
Journal:  Clin Rheumatol       Date:  2014-05-03       Impact factor: 2.980

Review 4.  Tenofovir and bone health.

Authors:  Philip M Grant; Aoife G Cotter
Journal:  Curr Opin HIV AIDS       Date:  2016-05       Impact factor: 4.283

5.  Effect of high-dose cholecalciferol (vitamin D3) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial.

Authors:  A J Rovner; V A Stallings; R Rutstein; J I Schall; M B Leonard; B S Zemel
Journal:  Osteoporos Int       Date:  2016-11-11       Impact factor: 4.507

6.  Bone Loss in HIV Infection.

Authors:  Caitlin A Moran; M Neale Weitzmann; Ighovwerha Ofotokun
Journal:  Curr Treat Options Infect Dis       Date:  2017-02-23

7.  Effects of Long-Term Tenofovir and Entecavir Treatment on Bone Mineral Density in Patients with Chronic Hepatitis B.

Authors:  Resul Kahraman; Abdurrahman Şahin; Oğuzhan Öztürk; Turan Çalhan; Süleyman Sayar; Evren Kanat; Levent Doğanay; Kamil Özdil
Journal:  Turk J Gastroenterol       Date:  2022-01       Impact factor: 1.555

8.  Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.

Authors:  Mutsawashe Bwakura-Dangarembizi; Victor Musiime; Alexander J Szubert; Andrew J Prendergast; Zvenyika A Gomo; Margaret J Thomason; Cuthbert Musarurwa; Peter Mugyenyi; Patricia Nahirya; Adeodata Kekitiinwa; Diana M Gibb; Ann S Walker; Kusum Nathoo
Journal:  Pediatr Infect Dis J       Date:  2015-02       Impact factor: 2.129

Review 9.  Drug-Induced Metabolic Acidosis.

Authors:  Amy Quynh Trang Pham; Li Hao Richie Xu; Orson W Moe
Journal:  F1000Res       Date:  2015-12-16

10.  Distal renal tubular acidosis without renal impairment after use of tenofovir: a case report.

Authors:  Kentaro Iwata; Manabu Nagata; Shuhei Watanabe; Shinichi Nishi
Journal:  BMC Pharmacol Toxicol       Date:  2016-11-21       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.